Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mangold

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Cancer Chemotherapy and Pharmacology|April 1, 1999
Evidence of enhanced in vivo activity using tirapazamine with paclitaxel and paraplatin regimens against the MV-522 human lung cancer xenograftS Weitman, G Mangold, J Marty, et al.
Anti-Cancer Drugs|August 1, 1997
Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxelX Zhang, H M Burt, G Mangold, et al.
The Bone & Joint Journal|June 1, 2019
Uniformly low serum cobalt levels after modular dual-mobility total hip arthroplasties with ceramic heads: a prospective study in high-risk patientsB P Chalmers, D G Mangold, A D Hanssen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxelX Zhang, H M Burt, D Von Hoff, et al.
British Journal of Cancer|July 29, 1999
A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assayE Raymond, D Sun, E Izbicka, et al.
Cancer Research|March 10, 1999
Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft modelC D Britten, S G Hilsenbeck, S G Eckhardt, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft modelL A Hammond, S G Hilsenbeck, S G Eckhardt, et al.
Cancer Research|July 23, 1999
Water soluble 20(S)-glycinate esters of 10,11-methylenedioxycamptothecins are highly active against human breast cancer xenograftsR M Wadkins, P M Potter, B Vladu, et al.
Investigative Ophthalmology & Visual Science|December 18, 1998
Transgenic mice with pigmented intraocular tumors: tissue of origin and treatmentN A Syed, J J Windle, S R Darjatmoko, et al.
Cancer Research|July 4, 1998
Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferaseA S Morgan, P E Sanderson, R F Borch, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Cancer Chemotherapy and Pharmacology|April 1, 1999
Evidence of enhanced in vivo activity using tirapazamine with paclitaxel and paraplatin regimens against the MV-522 human lung cancer xenograftS Weitman, G Mangold, J Marty, et al.
Anti-Cancer Drugs|August 1, 1997
Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxelX Zhang, H M Burt, G Mangold, et al.
The Bone & Joint Journal|June 1, 2019
Uniformly low serum cobalt levels after modular dual-mobility total hip arthroplasties with ceramic heads: a prospective study in high-risk patientsB P Chalmers, D G Mangold, A D Hanssen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxelX Zhang, H M Burt, D Von Hoff, et al.
British Journal of Cancer|July 29, 1999
A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assayE Raymond, D Sun, E Izbicka, et al.
Cancer Research|March 10, 1999
Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft modelC D Britten, S G Hilsenbeck, S G Eckhardt, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft modelL A Hammond, S G Hilsenbeck, S G Eckhardt, et al.
Cancer Research|July 23, 1999
Water soluble 20(S)-glycinate esters of 10,11-methylenedioxycamptothecins are highly active against human breast cancer xenograftsR M Wadkins, P M Potter, B Vladu, et al.
Investigative Ophthalmology & Visual Science|December 18, 1998
Transgenic mice with pigmented intraocular tumors: tissue of origin and treatmentN A Syed, J J Windle, S R Darjatmoko, et al.
Cancer Research|July 4, 1998
Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferaseA S Morgan, P E Sanderson, R F Borch, et al.
Pageof 4